Frequency of CDH1 Germline Mutations in Non-Gastric Cancers
Article 2021 en
Authors
GM
Giulia Massari
FM
Francesca Magnoni
GF
Giorgio Favia
Abstract
1 min read
Hereditary Diffuse Gastric Cancer (HDGC) is a complex inherited syndrome caused by <i>CDH1</i> germline mutations. DGC is the hallmark cancer of this genetic predisposition, but several other cancers are associated with these <i>CDH1</i> mutations. In this review, we revised all studies reporting <i>CDH1</i> mutations in non-GC patients. The selected studies included: (a) families aggregating with GC and other cancers, both, and (b) families presenting only non-gastric tumors association. Among non-gastric tumors, our results show that <i>CDH1</i> mutations are most frequently identified in breast cancer. The frequency of missense mutations is higher in the non-GC group, as the age at diagnosis in this group. Moreover, the predominant <i>CDH1</i> mutation affects the extracellular domain. Our data suggest that <i>CDH1</i> genetic testing should be considered also in other cancers, especially breast tumors.
Giovanni Corso, Federica Corso, Federica Bellerba, Patrı́cia Carneiro, Susana Seixas, Antonio Cioffi, Carlo La Vecchia, Francesca Magnoni, Bernardo Bonanni, Paolo Veronesi, Sara Gandini, Joana Figueiredo
Giovanni Corso, Joana Figueiredo, Carlo La Vecchia, Paolo Veronesi, Gabriella Pravettoni, Debora Macis, Rachid Karam, Roberto Lo Gullo, Elena Provenzano, Antonio Toesca, Ketti Mazzocco, Fátima Carneiro, Raquel Seruca, Soraia Melo, Fernando Schmitt, Franco Roviello, Alessandra Margherita De Scalzi, Mattia Intra, Irène Feroce, Elisa De Camilli, Maria Grazia Villardita, Chiara Trentin, Francesca De Lorenzi, Bernardo Bonanni,
Discussion(0)
No comments yet. Be the first to comment.